BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21258727)

  • 1. PDT-induced inflammatory and host responses.
    Firczuk M; Nowis D; Gołąb J
    Photochem Photobiol Sci; 2011 May; 10(5):653-63. PubMed ID: 21258727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP).
    Preise D; Scherz A; Salomon Y
    Photochem Photobiol Sci; 2011 May; 10(5):681-8. PubMed ID: 21258718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct tumor damage mechanisms of photodynamic therapy.
    Nowis D; Makowski M; Stokłosa T; Legat M; Issat T; Gołab J
    Acta Biochim Pol; 2005; 52(2):339-52. PubMed ID: 15990919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity.
    Garg AD; Nowis D; Golab J; Agostinis P
    Apoptosis; 2010 Sep; 15(9):1050-71. PubMed ID: 20221698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy.
    Peng Q; Moan J; Nesland JM
    Ultrastruct Pathol; 1996; 20(2):109-129. PubMed ID: 8882357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown.
    Garg AD; Krysko DV; Vandenabeele P; Agostinis P
    Photochem Photobiol Sci; 2011 May; 10(5):670-80. PubMed ID: 21258717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluence rate as a modulator of PDT mechanisms.
    Henderson BW; Busch TM; Snyder JW
    Lasers Surg Med; 2006 Jun; 38(5):489-93. PubMed ID: 16615136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of photodynamic therapy on tumor stroma.
    Peng Q; Nesland JM
    Ultrastruct Pathol; 2004; 28(5-6):333-40. PubMed ID: 15764581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The photobiology of photodynamic therapy: cellular targets and mechanisms.
    Oleinick NL; Evans HH
    Radiat Res; 1998 Nov; 150(5 Suppl):S146-56. PubMed ID: 9806617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
    Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
    Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B; Zupkó I; de Witte PA
    Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of photodynamic therapy.
    Krammer B
    Anticancer Res; 2001; 21(6B):4271-7. PubMed ID: 11908681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W; Lau W; Cheng C; Olivo M
    Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDT-associated host response and its role in the therapy outcome.
    Korbelik M
    Lasers Surg Med; 2006 Jun; 38(5):500-8. PubMed ID: 16634073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for enhancing antitumour immunity.
    Pizova K; Tomankova K; Daskova A; Binder S; Bajgar R; Kolarova H
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):93-102. PubMed ID: 22837129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A; Fisher AM; Rucker N; Gomer CJ
    Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
    Henderson BW; Sitnik-Busch TM; Vaughan LA
    Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
    J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tumor immunity by photodynamic therapy.
    Korbelik M
    J Clin Laser Med Surg; 1996 Oct; 14(5):329-34. PubMed ID: 9612200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.